The below article in The Times reports on the possibility of new treatments from an artificial intelligence tool that reads a cancer’s DNA :
Chai’s Chief Executive, Lisa Steele has commented:
“We welcome this very encouraging development and breakthrough in cancer treatment. Personalised care has been Chai’s hallmark for over 30 years and we understand that each diagnosis brings with it its own set of individual challenges for both the patient and their loved ones.
Operating from 11 centres across the UK, through its range of 66 specialised services, Chai provides support and care for each person who turns to us in the community impacted by a cancer diagnosis.”